These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 890700)

  • 21. Cytotoxic agents designed to be selective for liver cancer.
    Bukhari A; Connors TA; Gilsenan AM; Ross WC; Tisdale MJ; Warwick GP; Wilman DE
    J Natl Cancer Inst; 1973 Jan; 50(1):243-7. PubMed ID: 4692864
    [No Abstract]   [Full Text] [Related]  

  • 22. A powerful selection assay for mixture libraries of DNA alkylating agents.
    Ham YW; Boger DL
    J Am Chem Soc; 2004 Aug; 126(30):9194-5. PubMed ID: 15281804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Alkylating derivatives of 2-amino-2-deoxysugars and 1-methylamino-1-deoxypolyols (synthesis and experimental study)].
    Shkodinskaia EN; Dorn H; Vasina OS; Kashnikova NM; Kikot' BS
    Vopr Onkol; 1987; 33(11):48-53. PubMed ID: 3686922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzyme activated anti-tumour agents--III. Hydrolysis of conjugates of p-hydroxyaniline mustard in aqueous solution.
    Workman P; Double JA; Wilman DE
    Biochem Pharmacol; 1976 Nov; 25(21):2347-50. PubMed ID: 999722
    [No Abstract]   [Full Text] [Related]  

  • 25. Interrelationships of some chemical, physicochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas.
    Wheeler GP; Bowdon BJ; Grimsley JA; Lloyd HH
    Cancer Res; 1974 Jan; 34(1):194-200. PubMed ID: 4809457
    [No Abstract]   [Full Text] [Related]  

  • 26. Cell cycle effects of alkylating agents.
    Meyn RE; Murray D
    Pharmacol Ther; 1984; 24(2):147-63. PubMed ID: 6379683
    [No Abstract]   [Full Text] [Related]  

  • 27. Structure-activity studies on organoselenium alkylating agents.
    Kang SI; Spears CP
    J Pharm Sci; 1990 Jan; 79(1):57-62. PubMed ID: 2313578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
    Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
    Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hungarian anticancer drugs (antineoplastics).
    Kerpel-Fronius S
    Ther Hung; 1982; 30(3):110-21. PubMed ID: 6095482
    [No Abstract]   [Full Text] [Related]  

  • 30. [Structure and mode of action of alkylating agents used in the therapy of neoplastic diseases].
    Borresen HC
    Nord Med; 1969 Jan; 81(3):65-72. PubMed ID: 5767356
    [No Abstract]   [Full Text] [Related]  

  • 31. Hydroxamates: relationships between structure and plasma stability.
    Flipo M; Charton J; Hocine A; Dassonneville S; Deprez B; Deprez-Poulain R
    J Med Chem; 2009 Nov; 52(21):6790-802. PubMed ID: 19821586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Alkylating nucleosides. Synthesis and cytostatic activity of new types of halomethyl-substituted nucleosides].
    Pérez Méndez-Castrillón MP
    Rev Esp Oncol; 1984; 31(1):7-13. PubMed ID: 6545430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural quinones as quinonemethide precursors--ideas in rational drug design.
    Moore HW; Czerniak R; Hamdan A
    Drugs Exp Clin Res; 1986; 12(6-7):475-94. PubMed ID: 3461932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies with alkylating esters. VI. The chemical and biological activities of the isomers of dimethylmyleran.
    Jones AR
    Chem Biol Interact; 1973 Jan; 6(1):47-57. PubMed ID: 4689909
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanism of action of the nitrosoureas--1. Role of fluoroethylcytidine in the reaction of bis-fluoroethyl nitrosourea with nucleic acids.
    Tong WP; Ludlum DB
    Biochem Pharmacol; 1978 Jan; 27(1):77-81. PubMed ID: 619908
    [No Abstract]   [Full Text] [Related]  

  • 36. Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agents.
    Schmid FA; Otter GM; Mehta BM
    Cancer Res; 1985 Jan; 45(1):40-4. PubMed ID: 3965147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactions of 2,2-dimethylaziridine-type alkylating agents in biological systems II: comparative pharmacokinetics in dogs.
    Lalka D; Jusko WJ; Bardos TJ
    J Pharm Sci; 1975 Feb; 64(2):230-5. PubMed ID: 236372
    [No Abstract]   [Full Text] [Related]  

  • 38. [Method for the primary selection of active antitumor alkylating preparations in vitro and in vivo].
    Montsevichiute-Eringene EV
    Vopr Onkol; 1975; 21(10):73-7. PubMed ID: 1189354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving the spectrophotometric determination of the alkylating activity of anticancer agents: a new insight into the mechanism of the NBP method.
    Dierickx KM; Journé F; Gerbaux P; Morandini R; Kauffmann JM; Ghanem GE
    Talanta; 2009 Feb; 77(4):1370-5. PubMed ID: 19084651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactions of 2,2-dimethylaziridine-type alkylating agents in biological systems. I. Colorimetric estimation and stability in physiological media.
    Lalka D; Bardos TJ
    J Pharm Sci; 1973 Aug; 62(8):1294-8. PubMed ID: 4737580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.